|
🐜
|
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
16 auth.
L. Silverman,
K. Stevenson,
Jane E. O'Brien,
B. Asselin,
R. Barr,
L. Clavell,
P. Cole,
K. Kelly,
C. Laverdière,
B. Michon,
...
M. Schorin,
C. Schwartz,
Eileen Whyte O’Holleran,
D. Neuberg,
H. Cohen,
S. Sallan
|
8 |
2009 |
8
🐜
|
|
🐜
|
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
17 auth.
S. Lipshultz,
T. Miller,
R. Scully,
S. Lipsitz,
N. Rifai,
L. Silverman,
S. Colan,
D. Neuberg,
S. Dahlberg,
J. Henkel,
...
B. Asselin,
U. Athale,
L. Clavell,
C. Laverdière,
B. Michon,
M. Schorin,
S. Sallan
|
8 |
2012 |
8
🐜
|
|
🐜
|
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
19 auth.
Lynda M. Vrooman,
K. Stevenson,
J. Supko,
Jane E. O'Brien,
S. Dahlberg,
B. Asselin,
U. Athale,
L. Clavell,
K. Kelly,
J. Kutok,
...
C. Laverdière,
S. Lipshultz,
B. Michon,
M. Schorin,
M. Relling,
H. Cohen,
D. Neuberg,
S. Sallan,
L. Silverman
|
8 |
2013 |
8
🐜
|
|
🐜
|
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
24 auth.
S. Lipshultz,
S. Lipshultz,
R. Scully,
R. Scully,
S. Lipsitz,
S. Sallan,
S. Sallan,
L. Silverman,
L. Silverman,
T. Miller,
...
T. Miller,
E. Barry,
B. Asselin,
U. Athale,
L. Clavell,
E. Larsen,
A. Moghrabi,
Y. Samson,
B. Michon,
M. Schorin,
H. Cohen,
D. Neuberg,
E. Orav,
S. Colan
|
7 |
2010 |
7
🐜
|
|
🐜
|
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
23 auth.
A. Place,
K. Stevenson,
Lynda M. Vrooman,
M. Harris,
Sarah K. Hunt,
Jane E. O'Brien,
J. Supko,
B. Asselin,
U. Athale,
L. Clavell,
...
P. Cole,
K. Kelly,
C. Laverdière,
J. Leclerc,
B. Michon,
M. Schorin,
J. J. Welch,
S. Lipshultz,
J. Kutok,
Traci M. Blonquist,
D. Neuberg,
S. Sallan,
L. Silverman
|
7 |
2015 |
7
🐜
|
|
🦁
|
Complications of apheresis in children
12 auth.
B. Michon,
A. Moghrabi,
R. Winikoff,
S. Barrette,
M. Bernstein,
J. Champagne,
...
M. David,
M. Duval,
H. Hume,
N. Robitaille,
André Bélisle,
M. Champagne
|
7 |
2007 |
7
🦁
|
|
🐜
|
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia
13 auth.
Lynda M. Vrooman,
J. Supko,
D. Neuberg,
B. Asselin,
U. Athale,
L. Clavell,
K. Kelly,
C. Laverdière,
B. Michon,
M. Schorin,
...
H. Cohen,
S. Sallan,
L. Silverman
|
7 |
2010 |
7
🐜
|
|
🐜
|
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia
19 auth.
S. Lipshultz,
S. Lipsitz,
J. Kutok,
T. Miller,
S. Colan,
D. Neuberg,
Kristen Stevenson,
M. D. Fleming,
S. Sallan,
V. Franco,
...
J. Henkel,
B. Asselin,
U. Athale,
L. Clavell,
B. Michon,
C. Laverdière,
E. Larsen,
K. Kelly,
L. Silverman
|
7 |
2013 |
7
🐜
|
|
🐜
|
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
19 auth.
S. Lipshultz,
T. Miller,
S. Lipsitz,
D. Neuberg,
S. Dahlberg,
S. Colan,
L. Silverman,
J. Henkel,
V. Franco,
L. L. Cushman,
...
B. Asselin,
L. Clavell,
U. Athale,
B. Michon,
C. Laverdière,
M. Schorin,
E. Larsen,
N. Usmani,
S. Sallan
|
7 |
2012 |
7
🐜
|
|
🐜
|
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
17 auth.
Lynda M. Vrooman,
D. Neuberg,
K. Stevenson,
B. Asselin,
U. Athale,
L. Clavell,
P. Cole,
K. Kelly,
E. Larsen,
C. Laverdière,
...
B. Michon,
M. Schorin,
C. Schwartz,
H. Cohen,
S. Lipshultz,
L. Silverman,
S. Sallan
|
6 |
2011 |
6
🐜
|
|
🐜
|
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001.
21 auth.
Lynda M. Vrooman,
Traci M. Blonquist,
M. Harris,
K. Stevenson,
A. Place,
Sarah K. Hunt,
Jane E. O'Brien,
B. Asselin,
U. Athale,
L. Clavell,
...
P. Cole,
K. Kelly,
C. Laverdière,
J. Leclerc,
B. Michon,
M. Schorin,
M. Sulis,
J. J. Welch,
D. Neuberg,
S. Sallan,
L. Silverman
|
6 |
2018 |
6
🐜
|
